Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
53.06
+0.65 (1.24%)
At close: May 20, 2026, 4:00 PM EDT
52.95
-0.11 (-0.21%)
Pre-market: May 21, 2026, 4:07 AM EDT
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $30.55 billion as of May 20, 2026. Its market cap has increased by 65.07% in one year.
Market Cap
30.55B
Enterprise Value
38.92B
1-Year Change
65.07%
Ranking
Category
Stock Price
$53.06
Market Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $26.49B to $30.55B, an increase of 15.32%. That is a compound annual growth rate of 2.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 30.55B | 36.98% |
| Dec 31, 2025 | 22.30B | 48.40% |
| Dec 31, 2024 | 15.03B | -10.44% |
| Dec 29, 2023 | 16.78B | -30.07% |
| Dec 30, 2022 | 24.00B | -0.82% |
| Dec 31, 2021 | 24.20B | -20.37% |
| Dec 31, 2020 | 30.39B | 14.69% |
| Jun 16, 2020 | 26.49B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 49.39B |
| Alnylam Pharmaceuticals | 39.29B |
| BeOne Medicines AG | 33.02B |
| Revolution Medicines | 31.32B |
| Insmed | 23.28B |
| BioNTech SE | 22.20B |
| Roivant Sciences | 20.19B |
| Incyte | 19.10B |